Bank Of New York Mellon Corp Standard Biotools Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.93 - $1.52 $111,046 - $181,495	119,405 New	119,405 $139,000
Q3 2022 Nov 14, 2022	BUY	$1.1 - $2.06 $57,658 - $107,979	52,417 Added 103.5%	103,061 $113,000
Q2 2022 Aug 15, 2022	SELL	$1.6 - $3.99 $367,267 - $915,872	-229,542 Reduced 81.92%	50,644 $81,000
Q1 2022 May 11, 2022	SELL	$2.8 - $3.96 $19,082 - $26,987	-6,815 Reduced 2.37%	280,186 $1.01 Million
Q4 2021 Feb 11, 2022	BUY	$3.63 - $6.13 $17,993 - $30,386	4,957 Added 1.76%	287,001 $1.13 Million
Q3 2021 Nov 12, 2021	BUY	$5.5 - $7.41 $125,521 - $169,111	22,822 Added 8.8%	282,044 $1.86 Million
Q2 2021 Aug 11, 2021	SELL	$4.35 - $6.35 $217,804 - $317,944	-50,070 Reduced 16.19%	259,222 $1.6 Million
Q1 2021 May 13, 2021	SELL	$3.94 - $7.09 $610,179 - $1.1 Million	-154,868 Reduced 33.37%	309,292 $1.4 Million
Q4 2020 Feb 09, 2021	BUY	$5.45 - $8.65 $248,612 - $394,587	45,617 Added 10.9%	464,160 $2.78 Million
Q3 2020 Nov 12, 2020	SELL	$4.34 - $11.43 $332,938 - $876,841	-76,714 Reduced 15.49%	418,543 $3.11 Million
Q2 2020 Aug 12, 2020	SELL	$1.85 - $5.29 $98,458 - $281,539	-53,221 Reduced 9.7%	495,257 $1.99 Million
Q1 2020 May 06, 2020	BUY	$1.24 - $4.35 $33,047 - $115,931	26,651 Added 5.11%	548,478 $1.39 Million
Q4 2019 Feb 14, 2020	SELL	$2.3 - $5.12 $25,805 - $57,446	-11,220 Reduced 2.1%	521,827 $1.82 Million
Q3 2019 Nov 07, 2019	SELL	$4.63 - $12.15 $177,148 - $464,871	-38,261 Reduced 6.7%	533,047 $2.47 Million
Q2 2019 Aug 12, 2019	BUY	$11.49 - $14.17 $263,098 - $324,464	22,898 Added 4.18%	571,308 $7.04 Million
Q1 2019 May 14, 2019	BUY	$8.47 - $14.36 $760,004 - $1.29 Million	89,729 Added 19.56%	548,410 $7.29 Million
Q4 2018 Feb 11, 2019	BUY	$7.18 - $8.83 $210,445 - $258,807	29,310 Added 6.83%	458,681 $3.95 Million
Q3 2018 Nov 09, 2018	SELL	$5.92 - $8.35 $24,508 - $34,569	-4,140 Reduced 0.95%	429,371 $0
Q2 2018 Aug 06, 2018	BUY	$4.86 - $6.24 $170,542 - $218,967	35,091 Added 8.81%	433,511 $2.59 Million
Q1 2018 May 15, 2018	BUY	$5.75 - $7.97 $84,571 - $117,222	14,708 Added 3.83%	398,420 $2.33 Million
Q4 2017 Feb 09, 2018	BUY	$4.46 - $6.45 $1.71 Million - $2.47 Million	383,712	383,712 $2.26 Million

Others Institutions Holding LAB

# of Institutions

143

Shares Held

279M

Call Options Held

27.2K

Put Options Held

34.1K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $132M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account